Catalyst Wire Dossier Catalyst Wire Dossier

ZL-82 tablets

· Chengdu Zenitar Biomedical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZL-82 tablets, covering 2025-04-03 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis [Phase 2]

See pricing